Hantavirus infection in children in Argentina
Related Experiment Video
Updated: Oct 30, 2026

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
N C Pini1, A Resa, G del Jesús Laime
1Instituto Nacional de Enfermedades Virales Humanas, Pergamino, Argentina.
Abstract:
Clinical hantavirus infection was diagnosed in five Argentine children ages 5 to 11 years by immunoglobulin M (IgM)- capture enzyme-linked immunosorbent assay using Sin Nombre virus (SNV) antigens. Death in three of the children was associated with absence of detectable IgG to SNV antigens. An additional two cases in healthy children were studied: one, a breast-fed 15-month-old whose mother died of suspected hantavirus pulmonary syndrome (HPS) 8 months previously, had hantavirus IgG (> 1:6400); a second, whose mother survived HPS during month three of pregnancy, apparently had maternal antibodies no longer detectable 1 year after birth.
Related Concept Videos
Respiratory Syncytial Virus Disease
Poliomyelitis
Arboviral Encephalitis
Rabies
Rocky Mountain Spotted Fever

